-

AllerVie Health Expands Technology Infrastructure to Prioritize Innovation and Patient Experience

In 2023, AllerVie broadened its technology solutions nationwide with pulmonary function testing, a new electronic medical record system, and advanced respiratory health tools.

DALLAS--(BUSINESS WIRE)--Today, AllerVie Health, a leading national provider of allergy and immunology services, announced the extensive optimization of its digital infrastructure within clinics across 12 states in 2023. The growth of patient care-centered technology includes the integration of an innovative pulmonary function testing solution, the implementation of a new electronic medical record (EMR) system, and improving quality of care with remote respiratory monitoring devices. Additionally, the company is seamlessly upgrading IT hardware and software to support these new technology solutions.

"We are excited about our technology transformations this year and how they are enabling us to advance patient care and outcomes," said Chris Roussos, CEO of AllerVie Health. "This transformation was an enormous undertaking for our team and required deep collaboration with leading healthcare technology providers and clinical innovators. We look forward to bringing these advancements to our patients for the next generation of care."

Key highlights of digital advancements include:

Integration of Pulmonary Function Testing Solution
In 2023, AllerVie Health expanded its deployment of a state-of-the-art pulmonary function testing solution to 30 clinics nationwide. This device enhances pulmonary function testing to better diagnose and manage respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other lung-related disorders. This technology provides highly accurate and non-invasive pulmonary assessments to optimize patient care and enables fast and automated measurements of spirometry, lung volumes, and single-breath DLCO.

The comprehensive analysis and diagnostic data enable additional insights, contributing to better-informed medical decisions and personalized treatment.

New Electronic Medical Record System & Digital Patient Experience
AllerVie Health implemented a new electronic medical record (EMR) system in 14 clinics across Florida and Georgia during 2023. These advancements are designed to elevate patient care, allowing AllerVie to provide more comprehensive and secure healthcare services. The new patient portal will facilitate easier communication between providers and patients, ensuring a seamless and secure exchange of information and enhanced access to vital medical records.

Features include:

  • Secure messaging with providers
  • Convenient access to health records
  • Automated patient appointment reminders
  • Medication management and prescription refills
  • Digital check-in for routine allergy injection patients

The new EMR has been a go-forward solution for clinics in Alabama, Ohio, Florida, and Georgia, with the expanded rollout planned to reach 20+ clinic locations by the end of Q1 2024.

Cutting Edge Respiratory Health Tech
AllerVie Health's collaboration with a prominent digital health company specializing in respiratory health management broadens the utilization of a portable digital respiratory health tool and app across a more extensive range of clinics within the AllerVie Health network. This benefits patients with asthma, COPD, and cystic fibrosis. The life-saving device is currently being rolled out across AllerVie clinics spanning nine states, with plans to expand to additional states and clinics in the future.

The portable tool enables seamless communication between healthcare providers and patients, enhances patient engagement, and offers real-time insights to assist patients in minimizing unplanned hospital visits and reducing reliance on medications.

For more information about AllerVie's digital patient care advancements and latest developments, visit allervie.com.

About AllerVie Health
AllerVie Health is a national network of board-certified allergists and immunologists partnering together for the advancement of patient care, serving patients across 13 states in ~80+ clinic locations. Our providers are committed to establishing the allergy and immunology gold standard, expanding access to best-in-class care, and bringing relief and renewed vitality to the millions of Americans affected annually, many of whom live in underserved communities today. AllerVie is relentlessly dedicated to clinical excellence, creating an improved patient experience, and supporting the development of advanced allergy and immunology-focused therapeutics and treatment options. With AllerVie Health, our patients can feel their best, reclaim their lives, and live in freedom! To learn more, visit www.allervie.com.

Contacts

Chelsea Lambert
clambert@allervie.com
832.248.2340

AllerVie Health


Release Versions

Contacts

Chelsea Lambert
clambert@allervie.com
832.248.2340

More News From AllerVie Health

AllerVie Health Strengthens Leadership Team with VP Promotions and New Hire

DALLAS--(BUSINESS WIRE)--Today, AllerVie Health, a national network of allergy clinics, announces several key vice president promotions and a new hire to its executive team. These strategic leadership moves solidify AllerVie Health's position as a frontrunner in allergy and immunology, with a continued focus on delivering exceptional care. "Our recent executive promotions and addition of a new VP represent our commitment to building a strong leadership team capable of driving innovation and del...

AllerVie Health Names Rachel Russell as New Chief Experience Officer

DALLAS--(BUSINESS WIRE)--Today, AllerVie Health, a national network of allergy clinics, announced that Rachel Russell will be the company's new chief experience officer (CXO). The advancement from chief marketing, integration, and technology officer to CXO reflects AllerVie's ongoing dedication to enhancing the patient experience and continuing its strategic leadership succession plans. In her new role, Russell will lead the establishment of the AllerVie experience division, a team dedicated to...

AllerVie Health Names Tae Kim as New CEO

DALLAS--(BUSINESS WIRE)--Today, AllerVie Health, a national network of allergy clinics, announced Tae Kim will be the company's new chief executive officer. The advancement from president to CEO reflects the company's strategic plan. Chris Roussos, executive chairman of the board and former chief executive officer, will continue in his role on AllerVie's board as executive chairman, where he remains actively engaged in key strategic activities on behalf of the company. Kim, who joined AllerVie...
Back to Newsroom